Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clémentine Mirabel

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Stem Cell Research & Therapy|October 29, 2017
Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?Santiago Roura, Carolina Gálvez-Montón, Clémentine Mirabel, et al.
Journal of Translational Medicine|October 26, 2018
Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based productsClémentine Mirabel, Eduard Puente-Massaguer, Anna Del Mazo-Barbara, et al.
Regenerative Medicine|August 12, 2016
Qualification of computerized monitoring systems in a cell therapy facility compliant with the good manufacturing practicesAnna Del Mazo-Barbara, Clémentine Mirabel, Valentín Nieto, et al.
Vaccines|August 29, 2024
Formulation Development of a COVID-19 Recombinant Spike Protein-Based VaccineEmily Xiao, Clémentine Mirabel, Didier Clénet, et al.
Cells|May 24, 2019
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's JellyMarta Grau-Vorster, Luciano Rodríguez, Anna Del Mazo-Barbara, et al.
Cells|July 27, 2022
Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton's Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory ComplianceJoaquim Vives, Joaquim Hernández, Clémentine Mirabel, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Stem Cell Research & Therapy|October 29, 2017
Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?Santiago Roura, Carolina Gálvez-Montón, Clémentine Mirabel, et al.
Journal of Translational Medicine|October 26, 2018
Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based productsClémentine Mirabel, Eduard Puente-Massaguer, Anna Del Mazo-Barbara, et al.
Regenerative Medicine|August 12, 2016
Qualification of computerized monitoring systems in a cell therapy facility compliant with the good manufacturing practicesAnna Del Mazo-Barbara, Clémentine Mirabel, Valentín Nieto, et al.
Vaccines|August 29, 2024
Formulation Development of a COVID-19 Recombinant Spike Protein-Based VaccineEmily Xiao, Clémentine Mirabel, Didier Clénet, et al.
Cells|May 24, 2019
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's JellyMarta Grau-Vorster, Luciano Rodríguez, Anna Del Mazo-Barbara, et al.
Cells|July 27, 2022
Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton's Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory ComplianceJoaquim Vives, Joaquim Hernández, Clémentine Mirabel, et al.
Pageof 1